Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Crispr Therapeutics AG (CRSP) vs Estee Lauder Companies Inc (EL) Price & Performance

Crispr Therapeutics AGTrade
Estee Lauder Companies IncTrade

Price performance (Past 24H)

Key statistics

Crispr Therapeutics AG vs Estee Lauder Companies Inc — how do they compare? Crispr Therapeutics AG trades at $54.07 (market cap $5.23B), while Estee Lauder Companies Inc trades at $88.05 (market cap $31.76B). The key difference: Estee Lauder Companies Inc is far larger — about 6.1× Crispr Therapeutics AG's market cap, and Estee Lauder Companies Inc pays a 1.59% dividend while Crispr Therapeutics AG pays none. Which is the better fit depends on your goals.

CRSPEL
Market Cap
$5.23B$31.76B
Sector
HealthConsumer Staples
52-Week High
$76.78$119.61
52-Week Low
$44.34$67.23
Enterprise Value
$3.65B$37.93B
Dividend Yield
1.59%

Returns comparison

Trailing returns across standard periods

About Crispr Therapeutics AG

CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.

Read more on CRSP

About Estee Lauder Companies Inc

Estee Lauder is the world leader in the global prestige beauty market, participating across skincare (56% of fiscal 2022 sales), makeup (26%), fragrance (14%), and haircare (4%) categories, with popular brands such as Estee Lauder, Clinique, MAC, La Mer, Jo Malone, Aveda, Bobbi Brown, Too Faced, Origins, Dr. Jart+, and The Ordinary. The firm operates in 150 countries, with 26% of fiscal 2022 revenue stemming from the Americas, 43% from Europe, the Middle East, and Africa, and 31% from Asia-Pacific. The company sells its products through department stores, travel retail, multi-brand specialty beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.

Read more on EL